These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23221312)

  • 1. Impact of clinical and echocardiographic response to cardiac resynchronization therapy on long-term survival.
    Bertini M; Höke U; van Bommel RJ; Ng AC; Shanks M; Nucifora G; Auger D; Borleffs CJ; van Rijnsoever EP; van Erven L; Schalij MJ; Marsan NA; Bax JJ; Delgado V
    Eur Heart J Cardiovasc Imaging; 2013 Aug; 14(8):774-81. PubMed ID: 23221312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical abnormalities detected with conventional echocardiography are associated with response and midterm survival in CRT.
    Doltra A; Bijnens B; Tolosana JM; Borràs R; Khatib M; Penela D; De Caralt TM; Castel MÁ; Berruezo A; Brugada J; Mont L; Sitges M
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):969-79. PubMed ID: 25240452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator Therapy.
    van der Heijden AC; Höke U; Thijssen J; Willem Borleffs CJ; Wolterbeek R; Schalij MJ; van Erven L
    Am J Cardiol; 2016 Oct; 118(8):1217-1224. PubMed ID: 27586169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Echocardiographic Response to Cardiac Resynchronization Therapy in Initial Nonresponders.
    Burns KV; Gage RM; Curtin AE; Bank AJ
    JACC Heart Fail; 2015 Dec; 3(12):990-7. PubMed ID: 26577619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.
    Auger D; van Bommel RJ; Bertini M; Delgado V; Ng AC; Ewe SH; Shanks M; Marsan NA; Mooyaart EA; Witkowski T; Poldermans D; Schalij MJ; Bax JJ
    Am Heart J; 2010 Oct; 160(4):737-43. PubMed ID: 20934569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of visually assessed apical rocking and septal flash to response and long-term survival following cardiac resynchronization therapy (PREDICT-CRT).
    Stankovic I; Prinz C; Ciarka A; Daraban AM; Kotrc M; Aarones M; Szulik M; Winter S; Belmans A; Neskovic AN; Kukulski T; Aakhus S; Willems R; Fehske W; Penicka M; Faber L; Voigt JU
    Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):262-9. PubMed ID: 26588984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined baseline strain dyssynchrony index and its acute reduction predicts mid-term left ventricular reverse remodeling and long-term outcome after cardiac resynchronization therapy.
    Tatsumi K; Tanaka H; Matsumoto K; Miyoshi T; Hiraishi M; Tsuji T; Kaneko A; Ryo K; Fukuda Y; Norisada K; Onishi T; Yoshida A; Kawai H; Hirata K
    Echocardiography; 2014 Apr; 31(4):464-73. PubMed ID: 24138588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular dyssynchrony predicts clinical response to CRT - a long-term follow-up single-center prospective observational cohort study.
    Prinz C; Lehmann R; Schwarz M; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Lamp B; Horstkotte D; Faber L
    Echocardiography; 2013 Sep; 30(8):896-903. PubMed ID: 23489174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
    Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
    Höke U; Khidir MJ; van der Velde ET; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1740-8. PubMed ID: 26408549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of response to cardiac resynchronization therapy using left ventricular pacing lead position and cardiovascular magnetic resonance derived wall motion patterns: a prospective cohort study.
    Hartlage GR; Suever JD; Clement-Guinaudeau S; Strickland PT; Ghasemzadeh N; Magrath RP; Parikh A; Lerakis S; Hoskins MH; Leon AR; Lloyd MS; Oshinski JN
    J Cardiovasc Magn Reson; 2015 Jul; 17(1):57. PubMed ID: 26170046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy.
    Kydd AC; Khan FZ; Ring L; Pugh PJ; Virdee MS; Dutka DP
    Eur J Heart Fail; 2014 Nov; 16(11):1206-13. PubMed ID: 25302484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.